Offer - Urjas Oil for just Rs 1 X
Myostigmin 0.5 Injection is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Myasthenia Gravis. Myostigmin 0.5 Injection also has some secondary and off-label uses. These are listed below.
The right dosage of Myostigmin 0.5 Injection depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Myostigmin 0.5 Injection as well, which are listed below. These side effects of Myostigmin 0.5 Injection are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Myostigmin 0.5 Injection's effect is Unknown during pregnancy and Mild for lactating mothers. Warnings related to Myostigmin 0.5 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Myostigmin 0.5 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Arrhythmia, Peptic Ulcer, Asthma are examples of such conditions. Other contraindications of Myostigmin 0.5 Injection have been discussed in the sections ahead.
Drug interactions for Myostigmin 0.5 Injection have been reported in the medical literature. See below for a complete list.
You should also be aware that Myostigmin 0.5 Injection is not safe while driving, and is not addiction.
Myostigmin 0.5 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Myostigmin 0.5 Injection safe for pregnant women?
No research has not been done till date on the safety of Myostigmin for pregnant women. So its effects on pregnant women are unknown.
Is the use of Myostigmin 0.5 Injection safe during breastfeeding?
Side effects of Myostigmin for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Myostigmin 0.5 Injection on the Kidneys?
Myostigmin may have mild side effects on the kidneys.
What is the effect of Myostigmin 0.5 Injection on the Liver?
Myostigmin is completely safe for the liver.
What is the effect of Myostigmin 0.5 Injection on the Heart?
Very few cases of side effects of Myostigmin on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Myostigmin 0.5 Injection unless your doctor advises you to do so -
Is this Myostigmin 0.5 Injection habit forming or addictive?
Myostigmin 0.5 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Myostigmin 0.5 Injection. So it is best to avoid driving.
Is it safe?
There are no side effects of Myostigmin 0.5 Injection, so it is safe for use.
Is it able to treat mental disorders?
There is no benefit of taking Myostigmin 0.5 Injection for mental disorders.
Interaction between Food and Myostigmin 0.5 Injection
You can take Myostigmin 0.5 Injection with food.
Interaction between Alcohol and Myostigmin 0.5 Injection
Chances of side effects of drinking alcohol while taking Myostigmin 0.5 Injection are low. If you feel any adverse effects, please seek medical advice as soon as possible.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bloxiverz™ (Neostigmine Methylsulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 107